WEED.TO - Canopy Growth Corporation

Toronto - Toronto Delayed Price. Currency in CAD
59.70
-0.32 (-0.53%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close 60.02
Open 60.25
Bid 59.65 x 0
Ask 59.70 x 0
Day's Range 59.56 - 60.74
52 Week Range 31.81 - 76.68
Volume 1,039,574
Avg. Volume 2,435,424
Market Cap 20.601B
Beta (3Y Monthly) 5.04
PE Ratio (TTM) N/A
EPS (TTM) -1.79
Earnings Date N/A
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 76.91
  • 10 Canadian Marijuana Stocks for Your Portfolio
    Investopedia 7 hours ago

    10 Canadian Marijuana Stocks for Your Portfolio

    With marijuana headed for legalization in Canada, these penny stocks offer direct exposure and could help you get a piece of the pot.

  • Which Smaller Marijuana Stock Is Most Likely to Join Aurora Cannabis and Canopy Growth at the Top?
    Motley Fool 17 hours ago

    Which Smaller Marijuana Stock Is Most Likely to Join Aurora Cannabis and Canopy Growth at the Top?

    Three candidates appear to be at the top of the list.

  • Canada's Marijuana Sales Hit a Record High in March, but That's Not Saying Much
    Motley Fool 2 days ago

    Canada's Marijuana Sales Hit a Record High in March, but That's Not Saying Much

    Supply issues continue to wreak havoc on Canada's leading pot stocks.

  • In ‘the marijuana ghetto’ at Davos, Canopy Growth found its American pot partner
    MarketWatch 2 days ago

    In ‘the marijuana ghetto’ at Davos, Canopy Growth found its American pot partner

    The landmark deal between Acreage Holdings Inc. and Canopy Growth Corp. has its roots amid bunk beds inside a small, cramped house in Klosters, Switzerland.

  • Canopy’s proposed U.S. deal is a boon for the U.S. cannabis sector, says this investor
    MarketWatch 2 days ago

    Canopy’s proposed U.S. deal is a boon for the U.S. cannabis sector, says this investor

    Canopy Growth Corp.’s plan to acquire U.S. multi-state operator Acreage Holdings as soon as cannabis is legalized in the U.S. has won the support of a U.S. private-equity firm that specializes in investments in the cannabis sector.

  • Aphria leads cannabis stocks higher after Jefferies starts coverage with a buy rating
    MarketWatch 2 days ago

    Aphria leads cannabis stocks higher after Jefferies starts coverage with a buy rating

    Aphria Inc. shares soared about 9% Friday to lead the cannabis sector, after Jefferies started coverage of the stock with a buy rating.

  • How HEXO’s Valuation Stacks Up against Its Peers’
    Market Realist 3 days ago

    How HEXO’s Valuation Stacks Up against Its Peers’

    HEXO's Target Price Gets an Upgrade in May(Continued from Prior Part)HEXO’s valuationHEXO closed at 8.9 Canadian dollars on May 23, far from 7.8 Canadian dollars at the beginning of the year. With a return of more than 80%, the stock has received

  • 6 Marijuana Stocks With Critical Levels to Watch
    InvestorPlace 3 days ago

    6 Marijuana Stocks With Critical Levels to Watch

    In financial markets, there are certain price levels that are more significant than others with regard to the amount of supply and demand that exists at them. In addition, prices are always doing one of three things. They are either going up, going down or going nowhere. When understood and applied correctly, technical analysis is an illustration of these dynamics. Being aware of, and understanding where these levels and trends are when investing in marijuana stocks can lead to massive profits.Yes, technical analysts get a bad rap and I can understand why. Most technical analysts do not seem to understand the fundamentals. To make matters worse, some analysts employ esoteric techniques, such as Gann Theory, Harmonic Patterns or Elliot Waves. In my opinion there is no validity to such methods. They are in the realm of the Bigfoot and UFOs … fun to talk about, but hardly credible. Professional institutional traders do not pay attention to them.As someone who traded in the hedge fund world for more than twenty years, I can tell you first hand what the pros do care about: Important support and resistance levels, trends, momentum, and risk management.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 10 Names That Are Screaming Stocks to Buy Let's take a look and some of the supply-and-demand dynamics that are occurring in marijuana stocks. Knowing where the important levels and trends are can help you develop trading ideas. It can also and help you decide at which levels to place your buy and sell orders, and whether you should use market or limit orders. Read on for advice on how and where to trade the most popular pot stocks in the market today: Marijuana Stocks to Buy 2019: Aphria (APHA) Click to Enlarge Aphria (NYSE:APHA) grows and sells marijuana. In additional to cannabis, their products include things like capsules and vaporizers.On Monday the company announced that its President Jakob Ripshtein resigned. There has been considerable employee turnover in the upper echelons of management recently at Aphria. In January, CEO Vic Neufeld and Co-founder Cole Cacciavillani announced their resignation. Time will tell if these changes are a good or bad thing.The APHA stock price has fallen about 30% in the past month, but it just broke its downtrend after becoming oversold.It has been consolidating around the $7 level. In this situation, if I had been waiting to buy, I would go ahead and pull the trigger. This is because the downtrend line has been broken, possibly due to the sellers decision to cancel their orders on account of Ripshtein's resignation.There is nothing mysterious about trendlines -- they are really just logic and common sense. If used correctly, trendlines should simply be graphical representations of the supply and demand dynamics that are occurring in markets. When the trend was headed lower it meant that the forces of supply were in control. Now that the downtrend has been broken, it illustrates that the forces of demand have equalized with the forces of supply. Canopy Growth (CGC) Click to Enlarge Canopy Growth (NYSE:CGC) is also a producer and distributer of marijuana. In terms of market capitalization, it is the largest Cannabis company in the world.You don't need to be a market guru to see that the levels between $65 and $70 have been an area of resistance. Since last September every time CGC traded up to these levels, the forces of supply stepped in and drove it down.An important thing to understand about this company is that it loses money and CGC seems to be headed in the wrong direction. Last year the loss was 40 cents per share. That's nearly three times greater than the loss of 14 cents in 2017. In 2016, the loss was 5 cents per share. * 10 Small-Cap Stocks That Look Like Bargains This is a situation where, if I was considering selling, I would pull the trigger. If I was a buyer I would wait. The reasons are simple: Canopy stock is starting to trend lower and there is resistance just overhead. The path of least resistance seems to be to the downside. Aurora Cannabis (ACB) Click to Enlarge Aurora Cannabis (NYSE:ACB) sells a lot of weed. ACB just reported its last quarter's earnings and its gross margins came in at a hefty 55%. Further, revenue grew 20% to 65 million CAD, or roughly $50 million U.S. dollars. That works out to be about nine tons of the green stuff!It is clear that over the past eighteen months, the $14 level has been where the sellers come alive. It was the top in early 2018, again in September, and, most recently, in April. If you are planning on selling Aurora Cannabis stock, knowing this level is important.For example, suppose your broker or friend told you that ACB stock was worth $15 per share, suggesting you place your sell order at that level. The fact that there is a lot of supply at the $14 level may prevent the stock from getting to $15. It may make a better decision to place the order at $14. Sure, it is a lower price but it is probably better than having your order at $15 not be executed because the stock once again got to $14 and then proceeded to head lower.It is currently oversold and testing support around the $10.30 level. There is support there because it was resistance in November and January. Cronos Group (CRON) Click to Enlarge Cronos Group (NASDAQ:CRON) produces and sells cannabis in Canada and Germany. You don't need to be a master trader to see that the $14 level is important to the CRON stock price. This level acted as resistance for Cronos stock in September and December, and now it is providing support.Support levels form when a stock trades at a certain level and vested interest develops. In September and December, some investors sold short their CRON stock at $14. For a while, they were happy because they were thinking that they would be taking some profits. But in January, CRON traded above that.The short sellers are now underwater and looking at taking losses. They tell themselves that if the stock trades back down to $14, they would close out their trades and break even. This means that now there will be buy interest and the $14 level will become support.This is a situation where I would act whether I was a buyer or a seller. That is because it is either going to break support and fall or rebound and rise. One thing is for certain: It won't stay at $14 forever. * 10 Baby Boomer Stocks to Buy You have to make a decision to act whether you are bullish or bearish. If you are correct and you wait too long, you may miss out on some profits. Cannabis Sativa (CBDS) Click to Enlarge Cannabis Sativa, Inc (OTCMKTS:CBDS) is engaged in all types of business related to cannabis, They develop, acquire and license various products including edibles, recipes and delivery systems. Maybe they do too many things because the company has been losing money for years. Over the past five years it has lost about $40 million.CBDS stock has found support at prior support levels, though. This illustrates the importance of being aware of where the previous lows are. If you were considering buying CBDS shares and realized that it was in a downtrend and approaching levels that had been support in the past, then it would make sense to wait for a better price.Recently, Cannabis Sativa stock has broken its downtrend and is consolidating. That means that the forces of supply have become equal with the forces of demand. While it was trending lower the forces of supply were in control. Now the forces of supply and demand have become equalized. This is what traders call sideways trading. Horizons Marijuana Life Sciences ETF (HMLSF) Click to Enlarge Horizons Marijuana Life Sciences ETF (OTCMKS:HMLSF) is a popular exchange-traded fund (ETF). You can see that it is testing support around the $15 level. This level was support on April 15. It is important because it was resistance in March and June of last year. It is also important psychologically.Why is there support at this level? One reason is because there were investors who were considering buying it in April but never entered the trade. When they missed it, they told themselves that if it ever got back to $15, they would buy it. These dynamics form support.This is one of the reasons why professional traders pay attention when stocks are approaching levels that were recent tops or bottoms. They understand these dynamics and use them to profit. * 7 Stocks to Buy that Lost 10% Last Week The long-term importance of the $20 level is obvious. It was resistance at the beginning of last year and again in September and October. This would be a logical area to place a Good-Til-Cancelled (GTC) sell order.As of this writing, Mark Putrino did not hold a position in any of the aforementioned securities. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * 6 Stocks to Buy for This Decade's Massive Megatrend * The 7 Best Stocks to Buy From the IPO ETF * 7 Athletic Apparel Stocks With Marathon Pace Compare Brokers The post 6 Marijuana Stocks With Critical Levels to Watch appeared first on InvestorPlace.

  • Stock Market News: Clear Skies for Amazon; Canopy Makes Its Case to Cannabis Investors
    Motley Fool 3 days ago

    Stock Market News: Clear Skies for Amazon; Canopy Makes Its Case to Cannabis Investors

    The stock market regained some lost ground on Friday morning.

  • Cannabis Stocks Fell Due to Trade Fears
    Market Realist 4 days ago

    Cannabis Stocks Fell Due to Trade Fears

    Cannabis Stocks Fell Due to Trade FearsCannabis stocksOn May 23, Cannabis stocks fell due to renewed trade concerns. The benchmark ETFMG Alternative Harvest ETF (MJ) was trading 2.3% lower in the first half of the day.Stocks in the redAmong the

  • Canopy Growth and Acreage Holdings Announce Filing of Management Information Circulars Related to Canopy's Plan to Acquire Acreage
    PR Newswire 4 days ago

    Canopy Growth and Acreage Holdings Announce Filing of Management Information Circulars Related to Canopy's Plan to Acquire Acreage

    Canopy Growth's brands, technology and know-how is anticipated to provide Acreage with a significant and immediate advantage in an increasingly competitive U.S. market and fuel Acreage's growth. Acreage shareholders to receive immediate upfront cash consideration, on an as-converted to Subordinate Voting Share basis, of approximately US$2.51 - $2.63 per share upon the initial implementation of the Transaction. On completion of the Transaction, each Acreage share will be converted into 0.5818 of a common share of Canopy Growth, subject to any required adjustments.

  • /R E P E A T -- Meet Your New Neighbour: It's Tweed! Tweed Brings Its Unique Brand of Cannabis and Conversation to Meadow Lake, SK/
    CNW Group 4 days ago

    /R E P E A T -- Meet Your New Neighbour: It's Tweed! Tweed Brings Its Unique Brand of Cannabis and Conversation to Meadow Lake, SK/

    Tweed, Canada's top cannabis producer, is excited to announce the May 23rd grand opening of their Meadow Lake retail location with a celebration of fun, education and most importantly, community love! Legal cannabis is new to many consumers but we've been cutting our teeth as a medical producer for years so we can help suggest strains and educate on the different ways to consume cannabis.

  • 1 Reason Aurora Cannabis Does, and Doesn't, Need a Brand-Name Partner
    Motley Fool 4 days ago

    1 Reason Aurora Cannabis Does, and Doesn't, Need a Brand-Name Partner

    Millennials' favorite marijuana stock does need a partner, but probably not for the reason you've been told.

  • Canopy Growth stock climbs on news of U.K. skin-care deal; Hexo names COO
    MarketWatch 4 days ago

    Canopy Growth stock climbs on news of U.K. skin-care deal; Hexo names COO

    Cannabis stocks were mostly higher Wednesday, as investors digested the latest deal in the sector, Canopy Growth Corp.’s acquisition of a U.K. skin care company.

  • MarketWatch 5 days ago

    Canopy Growth investment arm Canopy Rivers appoints new CEO

    Canopy Rivers said late Wednesday it had appointed current president Narbé Alexandrian to the chief executive job. Until Wednesday, Canopy Growth Corp. CEO Bruce Linton served as interim CEO of Rivers. Linton will remain on Rivers' board as chairman. Canopy Rivers is the publicly traded venture capital-type unit of Canopy Growth, the world's largest weed company. Canopy Rivers stock closed up 2.9% during the regular session Wednesday and Canopy Growth stock closed up 2.3%. The S&P 500 index fell 0.3% Wednesday.

  • Meet Your New Neighbour: It's Tweed! Tweed Brings Its Unique Brand of Cannabis and Conversation to Meadow Lake, SK
    CNW Group 5 days ago

    Meet Your New Neighbour: It's Tweed! Tweed Brings Its Unique Brand of Cannabis and Conversation to Meadow Lake, SK

    Tweed, Canada's top cannabis producer, is excited to announce the May 23rd grand opening of their Meadow Lake retail location with a celebration of fun, education and most importantly, community love! Legal cannabis is new to many consumers but we've been cutting our teeth as a medical producer for years so we can help suggest strains and educate on the different ways to consume cannabis.

  • Canopy Growth Buys Skin Care Company In Latest CBD Deal; Marijuana Stocks Rise
    Investor's Business Daily 5 days ago

    Canopy Growth Buys Skin Care Company In Latest CBD Deal; Marijuana Stocks Rise

    Canadian cannabis producer Canopy Growth said it is buying This Works, a London-based skin care company, for around $55 million.

  • Why Canopy Growth Is on the Rise Today
    Market Realist 5 days ago

    Why Canopy Growth Is on the Rise Today

    Why Canopy Growth Is on the Rise TodayCanopy Growth acquires skincare companyOn May 22, Canopy Growth (WEED) (CGC) announced its acquisition of This Works, a natural wellness company based in London, England, for a total of 73.8 million Canadian

  • Reuters 5 days ago

    Canopy Growth pushes into cannabis beauty and wellness with This Works buy

    Canopy Growth Corp said on Wednesday it would buy skincare company This Works for C$73.8 million ($55.2 million), adding beauty and sleep products to the Canadian weed producer's portfolio of cannabis oil, hemp and medical capsules. London-based This Works, set up in 2003 by a former beauty director of Vogue UK and yoga teacher, makes pillow sprays that help users sleep faster, moisturizers to reduce wrinkles, body oils and eye-care products, according to its website. Canopy Growth said the acquisition fits with its strategy of expanding internationally and would help develop CBD-infused products and brands for the global beauty and wellness space.

  • Is Now a Good Time to Buy Cannabis Stocks?
    Market Realist 5 days ago

    Is Now a Good Time to Buy Cannabis Stocks?

    How Do Cannabis Stocks' Valuations Stack Up in May?(Continued from Prior Part)Investing in the cannabis sectorThe cannabis sector has had its ups and downs in the past month. The trend has mostly been flat to downwards-trending for most of the

  • Does Canopy Growth Look Attractive in May?
    Market Realist 5 days ago

    Does Canopy Growth Look Attractive in May?

    Canopy Growth: Analysts' Views in May(Continued from Prior Part)Canopy Growth’s valuationCanopy Growth (WEED) (CGC) is one of the few stocks that has traded at premium valuation multiples compared to its peers like Aurora Cannabis (ACB), Aphria

  • TheStreet.com 5 days ago

    Canopy Growth Buys London-Based Natural Skincare Company This Works

    shares were up 0.6% in premarket trading after the company announced that it purchased London-based skincare and sleep solutions company This Works for C$73.8 million. The company offers a range of natural skincare and sleep solution products, including a deep sleep pillow spray, morning expert hyaluronic serum and a dry leg oil. This Works CEO Anna Persaud will stay on as head of business operations after the acquisition with Canopy Growth supporting the company's current operations with an accelerated focus on global expansion and product development, including skincare and sleep solution products infused with CBD.

  • Canopy Growth: Analysts’ Views in May
    Market Realist 5 days ago

    Canopy Growth: Analysts’ Views in May

    Canopy Growth: Analysts' Views in MayCanopy GrowthCanopy Growth (WEED) (CGC) has been among the strongest cannabis bets for investors. In the past few months, more analysts have initiated coverage on the stock. In May, one more analyst initiated

  • Benzinga 5 days ago

    Canopy Growth Acquires London-Based Skincare Company This Works For $54M

    Canopy Growth Corp (NYSE: CGC ) is expanding in the wellness industry with the acquisition of London-based skincare and well-being company This Works . What Happened The acquisition will be done in all-cash. ...